1 INTRODUCTION {#SEC1}
==============

Large-scale studies in recent years have revealed that mammalian genomes encode thousands of long (\>200 nt) transcripts that lack coding capacity, but are otherwise messenger RNA-like. These are collectively referred to as long non-coding RNAs (lncRNAs) ([@B22]). Although their overall biological importance has been debated, early functional examples were discovered more than 20 years ago, notably *H19* ([@B6]) and *XIST* ([@B7]). Novel lncRNAs are now being uncovered at an increasing rate, with molecular functions that include recruitment of histone-modifying complexes to chromatin \[e.g. *HOTAIR* and *HOTTIP* ([@B24]; [@B27])\] and modulation of transcription and splicing by molecular interaction with relevant factors \[e.g. *GAS5* and *MALAT1* ([@B2]; [@B19])\].

A small number of studies describe interactions between small and lncRNAs, with lncRNAs acting either as inhibitory decoys of microRNAs ([@B11]) or as regulatory targets. In humans, miR-671 targets an antisense transcript of the human *CDR1* gene ([@B17]), and miR-29 can regulate the lncRNA *MEG3* in hepatocellular cancer, although only indirectly ([@B5]). Long non-coding transcripts that derive from ultra-conserved regions (T-UCRs) have also been suggested to be microRNA targets ([@B8]). In plants, the IPS1 lncRNA inhibits miR-399 through a sponge/decoy effect ([@B12]). Herpesvirus-encoded RNAs can bind and inhibit human host miR-27 ([@B9]), and the *HULC* lncRNA can bind and sequester miR-372 in liver cancer ([@B26]). A pseudogene of the *PTEN* tumor suppressor can compete for microRNA binding with its coding counterpart ([@B23]), and microRNA inhibition by lncRNAs is important during muscle differentiation ([@B10]). The decoy hypothesis is further supported by the observation that microRNAs with many targets in the cell tend to have a diluted effect on each individual target ([@B1]).

A recent study used lentiviral small hairpin RNAs to silence 147 lncRNAs at an average efficacy of 75% ([@B16]), demonstrating that lncRNAs in general are susceptible to regulation by Argonaute--small RNA complexes despite frequent nuclear localization. However, existing web-accessible microRNA target prediction databases, such as PicTar ([@B20]), miRanda ([@B3]) or TargetScan ([@B13]), are focused on 3^′^ -untranslated region (UTR) of coding genes and fail to provide predictions for the long non-coding transcriptome.

To simplify the study of microRNA--lncRNA interactions, we here describe miRcode: a comprehensive map of putative microRNA target sites across the GENCODE long non-coding transcriptome (10 419/15 977 lncRNAs genes/transcripts in the current version based on GENCODE V11). miRcode is designed to be an easy to use, web-based tool, with search functionalities to aid hypothesis generation starting from a lncRNA or microRNA of interest. Custom genome browser views and downloadable tab-delimited files are also accessible through the miRcode web interface. miRcode additionally covers other GENCODE gene classes, including 12 549 pseudogenes and 19 999 coding genes both in typical (3^′^-UTR) and atypical (5^′^-UTR and CDS) positions.

2 IMPLEMENTATION {#SEC2}
================

miRcode identifies putative target sites based on established principles: seed complementarity and evolutionary conservation (see [Supplementary Material](http://bioinformatics.oxfordjournals.org/cgi/content/full/bts344/DC1) for detailed methods). The seed region, encompassing bases 2--8 from the 5^′^-end of the microRNA, is the major sequence determinant of microRNA targeting ([@B21]). The miRcode pipeline ([Fig. 1](#F1){ref-type="fig"}), implemented using Perl, Matlab, PHP and MySQL, searches for complementary matches to established ([@B13]) microRNA seed families across GENCODE ([@B18]) transcripts. We consider 7-mers and adenosine-flanked 6-mer and 7-mer matches, but not 6-mers as these are only marginally effective ([@B15]; [@B25]). Fig. 1.Workflow for mapping of conserved putative microRNA target sites in lncRNAs

GENCODE represents a comprehensive, high-quality description of the polyA+ transcriptome. It is updated on a regular basis and based largely on full-length or near full-length complementary DNA evidence and additionally contains many known RNA genes and microRNAs. Although all of GENCODE is analyzed and accessible in miRcode, we define a subset of lncRNA genes that produce only predicted non-coding transcripts with a mature (spliced) length of \>200 nt. lncRNAs are further subdivided into intergenic (not overlapping with any coding gene) and non-intergenic.

To assess evolutionary conservation, a 46-way Multiz vertebrate genomic multiple alignment ([@B4]; [@B14]) is remapped onto transcripts, and site conservation levels are determined based on site presence in primates, non-primate mammals and non-mammal vertebrates. Transcript regions (3^′^-UTR, CDS and 5^′^-UTR in case of coding genes) and possible overlaps with repeat sequences are recorded for each site. Sites are mapped first to transcripts to allow identification of splice-junction-spanning sites, and subsequently aggregated into non-redundant gene-level sets. Predictions are finally made accessible through a web interface.

3 FUNCTIONALITY {#SEC3}
===============

The miRcode interface provides basic search functionality for finding putative microRNA--target sites in lncRNAs of interest or predicted targets of specific microRNAs. Sites are returned in the form of lists, aggregated on genes, where conservation levels (fraction of species where site is present) are presented separately for primates, non-primate placental mammals and non-mammal vertebrates. In addition, custom UCSC browser views enable browsing of target sites in a genome context. Tab-delimited text files and BED files provide convenient access to whole-transcriptome target predictions for use in computational projects.

In summary, we provide, in several formats, a pan-GENCODE microRNA site map to facilitate further investigation into microRNA regulation of lncRNAs as well as other atypical target regions such as pseudogenes and 5^′^-UTRs.
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